<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Big pharma stocks rise as Street reacts to latest presidential tariff plan</title>
    <link>https://www.taxtmi.com/news?id=57087</link>
    <description>The presidential announcement imposes pharmaceutical import tariffs while exempting companies that are &quot;breaking ground&quot; or &quot;under construction&quot; on U.S. manufacturing facilities, creating an enforcement focus on how those phrases are defined and raising legal challenge and compliance risks.</description>
    <language>en-us</language>
    <pubDate>Fri, 26 Sep 2025 19:01:03 +0530</pubDate>
    <lastBuildDate>Fri, 26 Sep 2025 19:01:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=854857" rel="self" type="application/rss+xml"/>
    <item>
      <title>Big pharma stocks rise as Street reacts to latest presidential tariff plan</title>
      <link>https://www.taxtmi.com/news?id=57087</link>
      <description>The presidential announcement imposes pharmaceutical import tariffs while exempting companies that are &quot;breaking ground&quot; or &quot;under construction&quot; on U.S. manufacturing facilities, creating an enforcement focus on how those phrases are defined and raising legal challenge and compliance risks.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 26 Sep 2025 19:01:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=57087</guid>
    </item>
  </channel>
</rss>